Diabetic Retinopathy Epidemiology

DelveInsight’s ‘Diabetic Retinopathy—Epidemiology Forecast—2034’ report delivers an in-depth understanding of the Diabetic retinopathy , historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Unlock comprehensive insights! Click Here to Purchase the Full Market Report @ Diabetic Retinopathy Treatment Market Size

Diabetic Retinopathy Disease Understanding

Diabetic retinopathy (DR) is a micro vascular disorder occurring due to long term effects of diabetes, leading to vision-threatening damage to the retina, eventually leading to blindness.

Diabetic retinopathy affects people with diagnosed or undiagnosed diabetes mellitus. The propensity of developing diabetic retinopathy is directly proportional to the age of the patient and duration of diabetes as well as with poor glycemic control and fluctuation blood pressure level.

Chronic hyperglycemia is considered as a primary pathogenic agent in DR. The morphological changes seen in small retinal vessels in DR include early loss of pericytes, basement membrane thickening, and loss of endothelial cells, increased vascular permeability, platelet aggregation, leukocytosis, and capillary dropout.

In the early stages, most people experience no signs of DR. Symptoms of DR include, blurred or distorted vision, new color blindness, night blindness, eye floaters, or streaks in vision, and trouble reading or seeing faraway objects.

DR develops in stages over time, including, background retinopathy, pre-proliferative retinopathy, and proliferative retinopathy.

Diabetic Retinopathy Epidemiology

The Diabetic retinopathy epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Diabetic retinopathy epidemiology segmented as the Total Prevalent cases of Diabetic retinopathy, Gender-specific of Diabetic retinopathy, Severity-specific cases of Diabetic Retinopathy, Age-specific cases of Diabetic Retinopathy. The report includes the Prevalent scenario of Diabetic retinopathy in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Diabetic Retinopathy Epidemiology

The epidemiology segment also provides the Diabetic retinopathy epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

• The total prevalent population of Diabetic retinopathy Associated in 7MM countries was estimated to be 23,185,393 cases in 2023 and expected to increase at a CAGR of 1.05% for the study period, i.e., 2021-2034.
• As per the estimates, United States has the highest prevalent population of Diabetic retinopathy in 7MM.
• Among the EU5 countries, France had the lowest prevalent population of Diabetic retinopathy. On the other hand, Germany had the highest number of cases, 2,763,918 cases in 2023.

Take Your Research to the Next Level! Click Here to Get Access to the Full Pipeline Report @ Diabetic Retinopathy New Drugs

Scope of the Report

• Diabetic retinopathy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Diabetic retinopathy Epidemiology Report and Model provide an overview of the risk factors and global trends of Diabetic retinopathy in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Diabetic retinopathy in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Diabetic retinopathy
• The report provides the segmentation of the Diabetic retinopathy epidemiology by prevalent Cases of Diabetic retinopathy in 7MM
• The report provides the segmentation of the Diabetic retinopathy epidemiology by Prevalence of Diabetic retinopathy , Prevalence of Diabetic retinopathy based on Clinical Manifestation, Gender-specific cases of Diabetic retinopathy , Diagnosed cases GCA in DR in 7MM

Report Highlights

• 10-year forecast of Diabetic retinopathy epidemiology
• 7MM Coverage
• Total Prevalent Cases of Diabetic retinopathy
• Gender-specific Prevalence of Diabetic retinopathy
• Severity-specific cases of Diabetic Retinopathy 
• Age-specific cases of Diabetic Retinopathy

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about Diabetic retinopathy?
• What are the key findings of Diabetic retinopathy epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2025-2034)?
• What would be the total number of patients with Diabetic retinopathy across the 7MM during the forecast period (2025-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?
• What are the disease risk, burden, and unmet needs of Diabetic retinopathy?
• What are the currently available treatments for Diabetic retinopathy?

Reasons to buy

The Diabetic Retinopathy Epidemiology report will allow the user to -

Develop business strategies by understanding the trends shaping and driving the global Diabetic retinopathy market

• Quantify patient populations in the global Diabetic retinopathy market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Diabetic retinopathy therapeutics in each of the markets covered
• Understand the magnitude of Diabetic retinopathy population by its prevalent cases
• Understand the magnitude of Diabetic retinopathy population by its clinical manifestation specific cases
• The Diabetic retinopathy epidemiology report and model was written and developed by Masters and PhD level epidemiologists
• The Diabetic retinopathy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Click Here to Read New Articles:- Latest DelveInsight Blogs